• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[术前回输自体血保存物处置的次要成本]

[Secondary costs of the disposition of preoperatively withdrawn autologous blood preserves].

作者信息

Diekamp U

机构信息

Bluttransfusionsdienst am Zentralkrankenhaus St.-Jürgen-Strasse, Bremen, Deutschland.

出版信息

Beitr Infusionsther Transfusionsmed. 1994;32:517-9.

PMID:9480155
Abstract

Preoperative autogenous blood (PAB) deposit programs are expensive. Aside from primary costs of preparing PAB, the user incurs major secondary costs from additional preadmission visits with the surgeon and from excess production, utilization and outdating of PAB (transfer into the allogeneic blood supply is not permitted here). These costs will exceed 200 Mio DM annually, increasing with better acceptance of PAB programs. However, PAB deposits are only indicated if transfusion incidence for the intended elective procedure exceeds 30%. Below that, preoperative, isovolemic hemodilution is considered the method of choice for limiting exposure to allogeneic blood.

摘要

术前自体血(PAB)储存计划成本高昂。除了制备PAB的主要成本外,用户还需承担因额外的术前与外科医生会诊以及PAB的过量生产、使用和过期(此处不允许转入异体血供应)而产生的主要次要成本。这些成本每年将超过2亿德国马克,并随着PAB计划的接受度提高而增加。然而,只有当预期择期手术的输血发生率超过30%时,才建议进行PAB储存。低于该比例时,术前等容血液稀释被认为是限制异体血接触的首选方法。

相似文献

1
[Secondary costs of the disposition of preoperatively withdrawn autologous blood preserves].[术前回输自体血保存物处置的次要成本]
Beitr Infusionsther Transfusionsmed. 1994;32:517-9.
2
[Comparison of production costs of allogenic and autologous blood preservation].异体和自体血液保存的生产成本比较
Beitr Infusionsther Transfusionsmed. 1994;32:505-11.
3
[Personnel need for preoperative establishment of autologous blood preservation compared with allogenic blood preservation].
Beitr Infusionsther Transfusionsmed. 1994;32:512-6.
4
[Personnel need and production costs of preparative thrombocytapheresis: an appropriate cost-benefit analysis?].
Beitr Infusionsther Transfusionsmed. 1994;32:520-3.
5
Clinical aspects of autologous transfusion.自体输血的临床方面。
Conn Med. 1979 Apr;43(4):201-5.
6
Autologous blood predonation in cardiac surgery.心脏手术中的自体血预存式献血
Transfus Clin Biol. 2007 Dec;14(6):526-9. doi: 10.1016/j.tracli.2008.02.002. Epub 2008 Apr 18.
7
[Preoperative autologous blood bank: communication, documentation, informed consent, iron supplement, testing, blood bank reports, cost control, transfusion].[术前自体血库:沟通、文件记录、知情同意、铁剂补充、检测、血库报告、成本控制、输血]
Beitr Infusionsther. 1990;26:257-60.
8
Transfusion practices among patients who did and did not predonate autologous blood before elective cardiac surgery.择期心脏手术前自体血预存患者与未预存患者的输血情况。
CMAJ. 1999 Apr 6;160(7):997-1002.
9
Autologous blood recovery. A guide for health care providers.自体血液回收。医护人员指南。
Physician Assist. 1993 Sep;17(9):55-6, 59.
10
Autologous blood donation in cardiac surgery: reduction of allogeneic blood transfusion and cost-effectiveness.心脏手术中的自体输血:减少异体输血及成本效益
J Cardiothorac Vasc Anesth. 2005 Oct;19(5):589-96. doi: 10.1053/j.jvca.2005.04.017.